Hepatocellular carcinoma (HCC) is on the rise worldwide and in the US, and despite emerging treatment modalities, its overall prognosis remains poor; therefore, there is a need for preventing its development globally
No takes yet. Share an insight, caveat, or question.
Sania Amr (2018) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: